Search Within

Hematologic Malignancies, Division of

Formats
  1. Meeting Abstract (6372)
  2. Journal Article (5781)
  3. Review (421)
  4. Editorial (196)
  5. Book Section (188)
  6. Research Letter (179)
  7. Guidelines (88)
  8. Conference Paper (65)
  9. Correspondence (62)
  10. Miscellaneous (18)
  11. Book Whole (9)
Groups
  1. Department of Medicine (13278)
  2. Center for Hematologic Malignancies (10612)
  3. GSK Faculty (4482)
  4. Adult Leukemia (3673)
  5. Bone Marrow Transplant (2848)
  6. Lymphoma (2705)

More Groups

People
  1. Sergio Giralt (1069)
  2. Miguel-Angel Perales (943)
  3. Ross Levine (787)
  4. Andrew Zelenetz (784)
  5. Steven Horwitz (669)
  6. Martin Tallman (655)

More People

Years
  1. 2025 (340)
  2. 2024 (823)
  3. 2023 (1038)
  4. 2022 (964)
  5. 2021 (875)
  6. 2020 (936)

More Years

Publications
  1. Blood (3529)
  2. Journal of Clinical Oncology (1233)
  3. Biology of Blood and Marrow Transplantation (596)
  4. Clinical Lymphoma, Myeloma and Leukemia (330)
  5. Haematologica (292)
  6. Bone Marrow Transplantation (239)

More Publications

Publishers
  1. American Society of Hematology (3806)
  2. Elsevier Inc. (1530)
  3. American Society of Clinical Oncology (1288)
  4. Nature Publishing Group (1009)
  5. American Association for Cancer Research (641)
  6. Wiley Blackwell (433)

More Publishers

Results (13379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Belantamab mafodotin (Belamaf) for relapsed/refractory multiple myeloma (RRMM): A real-world observational study
    Meeting Abstract

    Hultcrantz, M.; Kleinman, D.; Vij, R.; Escalante, F.; Kotowsky, N.; Bitetti, J.; Mackay, C.; Boytsov, N.; Camadoo-O'Byrne, L.; Germain, G.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Hypercalcemia in individuals with monoclonal gammopathy of undetermined significance: Results from the iStopMM study
    Meeting Abstract

    Jónsdóttir, Á. H.; Rögnvaldsson, S.; Sigurjónsdóttir, H. Á.; Thorsteinsdóttir, S.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B.; Sigurdardóttir, M.; Thorsteinsdottir, I.; Ólafsson, Í.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance and risk of chronic kidney disease: results of the population-based Iceland screens, treats, or prevents multiple myeloma (iStopMM) study
    Meeting Abstract

    Long, T. E.; Eythorsson, E.; Rognvaldsson, S.; Indridason, O.; Palsson, R.; Thorsteinsdóttir, S.; Sverrisdottir, I. S.; Aspelund, T.; Vidarsson, B.; Onundarson, P. T.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Monoclonal gammopathy of undetermined significance (MGUS) with multiple paraproteins: Results from the population-based iStopMM screening study
    Meeting Abstract

    Rögnvaldsson , S.; Oskarsson, J. Þ.; Thorsteinsdottir, S.; Reed, E. R.; Sigurdardottir, G. A.; Vidarsson, B.; Onundarson, P. T.; Sigurdardottir, M.; Agnarsson, B. A.; Olafsson, I.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Autoimmune diseases are not associated with monoclonal gammopathy of undetermined significance: Results of the prospective population-based iStopMM study
    Meeting Abstract

    Sverrisdottir, I. S.; Thorsteinsdóttir, S.; Rögnvaldsson, S.; Aspelund, T.; Vidarsson, B.; Önundarson, P. T.; Agnarsson, B.; Sigurdardóttir, M.; Thorsteinsdottir, I.; Sveinsdottir, S. V.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Evaluating stem cells to predict post-transplant relapse in the myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L. D. Jr; Awan, F. T.; Ramakrishnan, P.; Verma, K.; Vittrup, R.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Outcomes of therapies and resistance mutations following non-covalent Bruton's Tyrosine Kinase inhibitor treatment for patients with chronic lymphocytic leukemia and Richter Transformation
    Meeting Abstract

    Thompson, M. C.; Coombs, C. C.; Roeker, L. E.; Jensen, J. L.; Shah, N. N.; Luo, T.; Patel, K.; Bailey, N.; Fakhri, B.; Eyre, T. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Circulating tumor plasma cells in the screened iStopMM smoldering multiple myeloma cohort
    Meeting Abstract

    Thorsteinsdóttir, S.; Oskarsson, J. Þ.; Rögnvaldsson, S.; Gíslason, G.; Aspelund, T.; Sigurdardottir, G. Á; Thordardottir, Á. R.; Vidarsson, B.; Onundarson, P. T.; Agnarsson, B. A.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Incidence, clinical associations, and co-mutation patterns of UBA1 mutations in MDS
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Beck, D. B.; Creignou, M.; Domenico, D.; Farina, A.; Arango, J. E.; Kosmider, O.; Hasserjian, R. P.; Jadersten, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Five-year overall survival analysis using first- and second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia in the chronic phase in a prospective observational study (SIMPLICITY)
    Meeting Abstract

    Mauro, M.; Paquette, R.; Hehlmann, R.; Williams, L. A.; Goldberg, S. L.; Michallet, M.; Gambacorti-Passerini, C.; Tang, D.; DeGutis, I. S.; McBride, A.; more...
    Blood (2022)

    Fulltext@MSK | Save